SURAKSHA DIAGNOSTIC
Back to Balance Sheet
|
SURAKSHA DIAGNOSTIC Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹0.77 Cr | ₹0.45 Cr | ₹0.31 Cr | ₹0.11 Cr | - |
What is the latest Long Term Provisions ratio of SURAKSHA DIAGNOSTIC ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹0.77 Cr |
Mar2023 | ₹0.45 Cr |
Mar2022 | ₹0.31 Cr |
Mar2021 | ₹0.11 Cr |
Mar2020 | - |
How is Long Term Provisions of SURAKSHA DIAGNOSTIC Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹0.77 Cr | 70.95 | |
Mar2023 | ₹0.45 Cr | 45.02 | |
Mar2022 | ₹0.31 Cr | 182.73 | |
Mar2021 | ₹0.11 Cr | 0 | |
Mar2020 | - | - |
Compare Long Term Provisions of peers of SURAKSHA DIAGNOSTIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SURAKSHA DIAGNOSTIC | ₹1,551.0 Cr | 7.4% | 6.9% | NA | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹105,458.0 Cr | -3.5% | 9.5% | 23.9% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹101,699.0 Cr | 3.5% | 15.9% | 9.3% | Stock Analytics | |
FORTIS HEALTHCARE | ₹50,125.4 Cr | 1.5% | 9.8% | 50.9% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹37,907.9 Cr | 9.8% | 20.4% | 39% | Stock Analytics | |
GLOBAL HEALTH | ₹34,047.5 Cr | 3.2% | 7.5% | -7.2% | Stock Analytics |
SURAKSHA DIAGNOSTIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SURAKSHA DIAGNOSTIC | 7.4% |
6.9% |
|
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses